Phosphonate Lipid Tubules II
A R T I C L E S
Scheme 1. Synthesis of DC(8,9)PC Phosphonate Analog 3a
A suspension of the phosphonic acid, choline chloride (2.27 g, 16.3
mmol), and dry pyridine (125 mL) was heated to 60 °C under a N
2
atmosphere. Trichloroacetonitrile (15.23 mL) was added, and the
reaction was stirred at 60 °C for 44 h. The solvent was removed under
reduced pressure, and the residue was dissolved in CH Cl . Activated
2 2
carbon was added to the solution, and the mixture was filtered through
Celite. The filtrate was concentrated under reduced pressure, and the
crude product was purified by flash chromatography on silica gel using
3 3 2
CHCl /CH OH/H O (2:0.8:0.15) to give 1-[(S)-3,4-bis(10,12-tri-
cosadiynoyloxy)propyl] phosphonic acid, 2-(N,N,N-trimethylammo-
nium) ethyl ester 7 (580 mg). This material was further purified by
1
trituration with acetone to afford 347.8 mg (14.0%). H NMR: δ 5.24
(m, 1H), 4.57 (m, 1H), 4.34 (m, 2H), 4.07 (m, 1H), 3.81 (m, 2H), 3.35
(
bs, 9H), 2.24 (m, 12H), 1.90 (m, 2H), 1.26-1.55 (m, 56H), 0.88 (t,
6
7
5
H, J ) 6.5 Hz). 13C NMR (67.5 MHz): δ 173.3, 173.2, 77.60, 77.58,
7.39, 76.93, 71.80 (d, Jcp ) 15.3 Hz), 66.86, 65.28, 65.19, 64.85,
7.66, 54.54, 34.43 (d, Jcp ) 31.4 Hz), 31.86, 30.89, 29.61, 29.59,
a
29.57, 29.54, 29.51, 29.48, 29.45, 29.43, 29.41, 29.39, 29.28, 29.12,
(
a) Pb(OAc)4, NaBH4; (b) P(Ph)3, CBr4; (c) P(OEt)3, ∆; (d) p-TsOH,
EtOH; (e) 10,12-tricosadiynoic acid, DMAP, DCC, CH2Cl2; (f) (CH3)3SiBr,
CH2Cl2, THF, H2O; (g) choline chloride, Cl3CCN, pyridine.
29.07, 28.93, 28.84, 28.80, 28.33, 25.60, 24.87 (d, Jcp ) 17.3 Hz),
22.65, 19.17, 14.10. 31P NMR (132 MHz, 85% H
PO
3
4
external
reference): δ 18.59. HRMS calcd for C54H93NO P: 898.6689. Found:
7
phosphite (12 mL, 70.0 mmol) was refluxed for 14 h. The residual
triethyl phosphite was removed under reduced pressure, and the crude
product was purified by flash chromatography on silica gel using ethyl
acetate to give diethyl [(R)-O-3,4-isopropylidene-3,4-dihydroxypropyl]
898.6685.
II.b. Physical Characterization. II.b.1. Tubule Preparation.
DC(8,9)PC and “C3” phosphonate tubules were prepared by adding 1
mg of lipid to 1 mL of EtOH/H O solvent, heating to 50 °C with
2
1
phosphonate 6 (2.37 g, 89.4%). H NMR: δ 4.38 (m, 1H), 4.13 (m,
vigorous stirring, and cooling the clear solutions to room temperature
to obtain flocculent off-white precipitates. Solvent compositions that
maximized precipitate yields for DC(8,9)PC and the “C3” phosphonate
3 were 0.7:0.3 and 0.6:0.4 (v:v), respectively; these solvent compositions
were used throughout the work presented in this report. It has been
shown that DC(8,9)PC tubule lengths depend not only upon the solvent
composition, but upon the rate at which the spherical vesicles from
which they form are cooled18 as well. Accordingly, the DC(8,9)PC and
the “C3” phosphonate preparations were driven through their tubule
formation temperatures (38 and 37 °C for DC(8,9)PC and the “C3”
phosphonate, respectively) at the same rate, 12.8 °C/h. Tubule yields
were determined by centrifuging and desiccating the precipitate to
constant mass.
5
H), 3.68 (dd, 1H, J ) 11 Hz, 7.5 Hz), 2.33-1.91 (m, 2H), 1.43-1.11
(m, 12H).
II.a.5. Diethyl [(R)-3,4-Dihydroxypropyl] Phosphonate (7). A
solution of 6 (1.91 g, 7.6 mmol) and p-toluenesulfonic acid (211 mg,
.1 mmol) in ethanol (70 mL) was stirred for 14 h at room temperature
under a N atmosphere. The mixture was neutralized with solid sodium
bicarbonate, filtered, and concentrated under reduced pressure. The
residue was brought up in CHCl (50 mL) and filtered through Celite.
This material was concentrated under reduced pressure and purified
by flash chromatography on silica gel using CHCl /CH OH (7:1) to
1
17
2
3
3
3
give diethyl [(R)-3,4-dihydroxypropyl] phosphonate 7 (1.06 g, 66.3%).
1
H NMR: δ 4.12 (m, 5H), 3.70 (m, 1H), 3.54 (dd, 1H, J ) 12 Hz, 6
Hz), 2.42 (bs, 2H), 2.12-1.87 (m, 2H), 1.35 (dt, 6H, J ) 7.5 Hz, 3
Hz).
II.b.2. Optical Microscopy. Differential interference contrast mi-
croscopy (DIC) was conducted with a Nikon Diaphot 300 inverted
microscope equipped with 60× and 100× Nomarski objectives, and
images were digitized using a Dage VE1000 CCD video camera
coupled to a high-resolution video capture board or were photographed
with a Nikon N6006 35 mm camera. Tubule lengths were tabulated on
a Macintosh computer using the public domain NIH Image program,
developed at the U.S. National Institutes of Health, and are available
on the Internet at http://rsb.info.nih.gov/nih-image/. All specimens were
handled as gently as possible to minimize tubule breakage.
II.a.6. Diethyl [(S)-3,4-Bis(10,12-tricosadiynoyloxy)propyl] Phos-
phonate (8). A solution of 1,3-dicyclohexylcarbodiimide (2.27 g, 11.0
mmol) in dry CH
phosphonate 7 (1.06 g, 5.0 mmol), 10,12-tricosadiynoic acid (3.64 g,
0.5 mmol), and (dimethylamino)pyridine (128.3 mg, 1.05 mmol) in
dry CH Cl (35 mL) and was stirred under a N atmosphere. After
2 2
Cl (7 mL) was added to a stirred solution of diethyl
1
2
2
2
stirring for 48 h at room temperature, the reaction mixture was filtered
through Celite, and the filtrate was evaporated to furnish a light-yellow
solid. The solid was purified by flash chromatography on silica gel
using hexane/ethyl acetate (2:1) to give diethyl [(R)-3,4-bis(10,12)-
II.b.3. Atomic Force Microscopy. Contact- and tapping-mode
atomic force microscopy probes were conducted on a vibrationally and
thermally isolated Digital Instruments BioScope, equipped with silicon
nitride NanoProbe SPM tips. Tubule external diameters were measured
by determining the perimeter of the cross-sectional AFM trace of the
tubule and dividing by π. Finite tip-size convolution error has been
found to be negligible.19 Local membrane elasticity probes were
conducted on a Digital Instruments Nanoscope IIIa Multi-Mode
1
tricosadiynoyloxy)propyl] phosphonate 8 (3.06 g, 70.4%). H NMR:
δ 5.36 (m, 1H), 4.40 (dd, 1H, J ) 12 Hz, 3 Hz), 4.12 (m, 5H), 2.37-
2
.11 (m, 14H), 1.70-1.20 (m, 62H), 0.93 (t, 6H, J ) 7.5 Hz).
II.a.7. 1-[(S)-3,4-Bis(10,12-tricosadiynoyloxy)propyl] Phosphonic
Acid, 2-(N,N,N-Trimethylammonium) Ethyl Ester (3). Bromotri-
methylsilane (1.21 mL, 9.91 mmol) was added over a period of 1 h to
a stirred solution of diethyl [(S)-3,4-bis(10,12-tricosadiynoyloxy)propyl]
19
scanning probe microscope using oxide-sharpened silicon nitride tips.
phosphonate 8 (3.06 g, 3.52 mmol) in dry CH
2
Cl
2
(7 mL) under a N
2
II.b.4. X-ray Diffraction. High-resolution small-angle X-ray scat-
tering was done at Beamline X20A of the National Synchrotron Light
Source at Brookhaven National Laboratory. X-rays (1.6122 Å) were
atmosphere. Six hours after completion of the addition, the reaction
mixture was concentrated in vacuo, the residue was brought up in
aqueous THF (10%, 15 mL), and the solution was heated at reflux for
-
1
used with an in-plane resolution of 0.0007 Å , commensurate with
the Ge[1,1,1] analyzer crystal, while out-of-plane resolution was relaxed
9
0 min. The solvent was removed under reduced pressure, and the
residue was dissolved in CHCl (30 mL). The CHCl solution was dried
Na SO ), filtered, and concentrated under reduced pressure to give
.80 g (98%) of phosphonic acid which was utilized without any further
purification (Scheme 1).
-
1
3
3
to 0.008 Å to increase signal intensity. Tubule samples of c ≈ 100
mg lipid/mL were prepared by centrifuging at 10 000g at 20 °C for 30
min; optical microscopy of the resuspended pellet revealed no discern-
ible change in tubule morphology induced by centrifugation. This
(
2
2
4
J. AM. CHEM. SOC.
9
VOL. 124, NO. 7, 2002 1229